These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32049654)

  • 21. Clinical characteristics and genotypes in the ADVANCE baseline data set, a comprehensive cohort of US children and adolescents with Pompe disease.
    Kishnani PS; Gibson JB; Gambello MJ; Hillman R; Stockton DW; Kronn D; Leslie ND; Pena LDM; Tanpaiboon P; Day JW; Wang RY; Goldstein JL; An Haack K; Sparks SE; Zhao Y; Hahn SH;
    Genet Med; 2019 Nov; 21(11):2543-2551. PubMed ID: 31086307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reevaluating the pathogenicity of the mutation c.1194 +5 G>A in GAA gene by functional analysis of RNA in a 61-year-old woman diagnosed with Pompe disease by muscle biopsy.
    Amiñoso C; Gordillo-Marañón M; Hernández J; Solera J
    Neuromuscul Disord; 2019 Mar; 29(3):187-191. PubMed ID: 30770309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease-associated variants, common sequence variants, and results from newborn screening.
    de Faria DOS; 't Groen SLMI; Hoogeveen-Westerveld M; Nino MY; van der Ploeg AT; Bergsma AJ; Pijnappel WWMP
    Hum Mutat; 2021 Feb; 42(2):119-134. PubMed ID: 33560568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations.
    Herzog A; Hartung R; Reuser AJ; Hermanns P; Runz H; Karabul N; Gökce S; Pohlenz J; Kampmann C; Lampe C; Beck M; Mengel E
    Orphanet J Rare Dis; 2012 Jun; 7():35. PubMed ID: 22676651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas9 generated Pompe knock-in murine model exhibits early-onset hypertrophic cardiomyopathy and skeletal muscle weakness.
    Huang JY; Kan SH; Sandfeld EK; Dalton ND; Rangel AD; Chan Y; Davis-Turak J; Neumann J; Wang RY
    Sci Rep; 2020 Jun; 10(1):10321. PubMed ID: 32587263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Therapy for Pompe Disease: The Time is now.
    Colella P; Mingozzi F
    Hum Gene Ther; 2019 Oct; 30(10):1245-1262. PubMed ID: 31298581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
    Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
    Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of two different homozygote mutations in Pompe disease.
    Arslan A; Poyrazoğlu HG; Kiraz A; Özcan A; Işık H; Ergul AB; Mungan NÖ; Streubel B; Ceylaner S; Altuner Torun Y
    Pediatr Int; 2016 Mar; 58(3):241-243. PubMed ID: 26946079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare Variants in Autophagy and Non-Autophagy Genes in Late-Onset Pompe Disease: Suggestions of Their Disease-Modifying Role in Two Italian Families.
    Napolitano F; Bruno G; Terracciano C; Franzese G; Palomba NP; Scotto di Carlo F; Signoriello E; De Blasiis P; Navarro S; Gialluisi A; Melone MAB; Sampaolo S; Esposito T
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The genotype-phenotype correlation in Pompe disease.
    Kroos M; Hoogeveen-Westerveld M; van der Ploeg A; Reuser AJ
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):59-68. PubMed ID: 22253258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct disease phenotypes linked to different combinations of GAA mutations in a large late-onset GSDII sibship.
    Sampaolo S; Esposito T; Farina O; Formicola D; Diodato D; Gianfrancesco F; Cipullo F; Cremone G; Cirillo M; Del Viscovo L; Toscano A; Angelini C; Di Iorio G
    Orphanet J Rare Dis; 2013 Oct; 8():159. PubMed ID: 24107549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-mortem diagnosis of Pompe disease by exome sequencing in a Moroccan family: a case report.
    Adadi N; Sahli M; Egéa G; Ratbi I; Taoudi M; Zniber L; Jdioui W; El Mouatassim S; Sefiani A
    J Med Case Rep; 2018 Oct; 12(1):322. PubMed ID: 30371346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homozygosity for the common GAA gene splice site mutation c.-32-13T>G in Pompe disease is associated with the classical adult phenotypical spectrum.
    Musumeci O; Thieme A; Claeys KG; Wenninger S; Kley RA; Kuhn M; Lukacs Z; Deschauer M; Gaeta M; Toscano A; Gläser D; Schoser B
    Neuromuscul Disord; 2015 Sep; 25(9):719-24. PubMed ID: 26231297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II.
    Wan L; Lee CC; Hsu CM; Hwu WL; Yang CC; Tsai CH; Tsai FJ
    J Neurol; 2008 Jun; 255(6):831-8. PubMed ID: 18458862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex Transposon Insertion as a Novel Cause of Pompe Disease.
    Bychkov I; Baydakova G; Filatova A; Migiaev O; Marakhonov A; Pechatnikova N; Pomerantseva E; Konovalov F; Ampleeva M; Kaimonov V; Skoblov M; Zakharova E
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II.
    McCready ME; Carson NL; Chakraborty P; Clarke JT; Callahan JW; Skomorowski MA; Chan AK; Bamforth F; Casey R; Rupar CA; Geraghty MT
    Mol Genet Metab; 2007 Dec; 92(4):325-35. PubMed ID: 17723315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects.
    Colella P; Sellier P; Gomez MJ; Biferi MG; Tanniou G; Guerchet N; Cohen-Tannoudji M; Moya-Nilges M; van Wittenberghe L; Daniele N; Gjata B; Krijnse-Locker J; Collaud F; Simon-Sola M; Charles S; Cagin U; Mingozzi F
    EBioMedicine; 2020 Nov; 61():103052. PubMed ID: 33039711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GAA gene mutation detection following clinical evaluation and enzyme activity analysis in Azeri Turkish patients with Pompe disease.
    Gharesouran J; Jalaiei A; Hosseinzadeh A; Ghafouri-Fard S; Mokhtari Z; Ghahremanzadeh K; Rezazadeh N; Shiva S; Sadeghvand S; Taheri M; Rezazadeh M
    Metab Brain Dis; 2020 Oct; 35(7):1127-1134. PubMed ID: 32504392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation.
    Liu X; Wang Z; Jin W; Lv H; Zhang W; Que C; Huang Y; Yuan Y
    BMC Med Genet; 2014 Dec; 15():141. PubMed ID: 25526786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Mutations Found in Individuals with Adult-Onset Pompe Disease.
    Aung-Htut MT; Ham KA; Tchan MC; Fletcher S; Wilton SD
    Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 32012848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.